Abstract
Bongkrekic acid (BKA), an antibiotic isolated from Pseudomonas cocovenans, is an inhibitory molecule of adenine nucleotide translocase. Since this translocase is a core component of the mitochondrial permeability transition pore (MPTP) formed by apoptotic stimuli, BKA has been used as a tool to abrogate apoptosis. However, the other biochemical properties of BKA have not yet been resolved. Although the definition of a fatty acid is a carboxylic acid (-COOH) with a long hydrocarbon chain (tail), when focused on the chemical structure of BKA, the molecule was revealed to be a branched unsaturated tricarboxylic acid that resembled the structure of polyunsaturated fatty acids (PUFAs). Peroxisome proliferator-activated receptors (PPARs) consist of a subfamily of three isoforms: α, β, and γ, the ligands of which include PUFAs. Using completely synthesized BKA together with simplified BKA derivatives (purity: > 98%), we herein demonstrated the utility of BKA as a selective activator of the human PPARγ isoform, which may not be associated with the anti-apoptotic nature of BKA. We also discussed the possible usefulness of BKA.
References
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M GöttlicherJ A Gustafsson
Aug 1, 1989·Prostaglandins·D DaretJ Larrue
Nov 3, 1987·Biochemistry·C KemalA L Shorter
Jan 1, 1995·Physiological Reviews·F B HillgartnerA G Goodridge
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerJ M Lehmann
Sep 23, 1998·Nature·R T NolteM V Milburn
Jul 8, 1999·Molecular Cell·P SarrafC Eng
Apr 27, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·G CaoJ Chen
Aug 2, 2001·Nature Medicine·T YamauchiT Kadowaki
Feb 15, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·T M LarsenA Astrup
May 28, 2005·Neuroscience Letters·Marianna Muranyi, Ping-An Li
Nov 17, 2005·Oncogene·X ZuoI Shureiqi
Apr 15, 2008·Biochimica Et Biophysica Acta·Anna W C Leung, Andrew P Halestrap
Jan 28, 2009·Nature Structural & Molecular Biology·Toshimasa ItohJohn W R Schwabe
May 2, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shuso TakedaKazuhito Watanabe
May 12, 2009·Toxicology·Shuso TakedaKazuhito Watanabe
Apr 24, 2010·Nuclear Receptor Signaling·Sean R PyperJanardan K Reddy
Oct 5, 2010·Journal of Pharmaceutical Sciences·Shuso TakedaKazuhito Watanabe
May 5, 2011·The Journal of Clinical Investigation·Dontscho KerjaschkiGeorg Krupitza
Aug 2, 2011·Biological & Pharmaceutical Bulletin·Shuso TakedaHironori Aramaki
Oct 15, 2011·Diabetes·Dimitri FavreAmar Abderrahmani
Feb 10, 2012·Nature Reviews. Cancer·Jeffrey M PetersFrank J Gonzalez
Sep 25, 2012·Chemical Research in Toxicology·Katsuhiro OkudaMitsuru Shindo
Mar 29, 2013·The Journal of Toxicological Sciences·Shuso TakedaHironori Aramaki
Oct 8, 2014·Toxicology·Shuso TakedaHironori Aramaki